The unique second wave phenomenon in contrast enhanced ultrasound imaging with nanobubbles.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
10 08 2022
10 08 2022
Historique:
received:
10
01
2022
accepted:
30
07
2022
entrez:
10
8
2022
pubmed:
11
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
Investigation of nanobubble (NB) pharmacokinetics in contrast-enhanced ultrasound (CEUS) at the pixel level shows a unique phenomenon where the first pass of the contrast agent bolus is accompanied by a second wave. This effect has not been previously observed in CEUS with microbubbles. The objective of this study was to investigate this second-wave phenomenon and its potential clinical applications. Seven mice with a total of fourteen subcutaneously-implanted tumors were included in the experiments. After injecting a bolus of NBs, the NB-CEUS images were acquired to record the time-intensity curves (TICs) at each pixel. These TICs are fitted to a pharmacokinetic model which we designed to describe the observed second-wave phenomenon. The estimated model parameters are presented as parametric maps to visualize the characteristics of tumor lesions. Histological analysis was also conducted in one mouse to compare the molecular features of tumor tissue with the obtained parametric maps. The second-wave phenomenon is evidently shown in a series of pixel-based TICs extracted from either tumor or tissues. The value of two model parameters, the ratio of the peak intensities of the second over the first wave, and the decay rate of the wash-out process present large differences between malignant tumor and normal tissue (0.04 < Jessen-Shannon divergence < 0.08). The occurrence of a second wave is a unique phenomenon that we have observed in NB-CEUS imaging of both mouse tumor and tissue. As the characteristics of the second wave are different between tumor and tissue, this phenomenon has the potential to support the diagnosis of cancerous lesions.
Identifiants
pubmed: 35948582
doi: 10.1038/s41598-022-17756-1
pii: 10.1038/s41598-022-17756-1
pmc: PMC9365822
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13619Subventions
Organisme : NIH HHS
ID : 1S10OD021635-01
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
D. Maulik, I. Zalud, Doppler ultrasound in obstetrics and gynecology. (Springer, 2005).
Claudon, M. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall in der Medizin-Eur. J. Ultrasound 29, 28–44 (2008).
doi: 10.1055/s-2007-963785
Krix, M. et al. Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: Quantification of tumour perfusion in small animals. Ultrasound Med. Biol. 29, 1093–1103 (2003).
pubmed: 12946512
doi: 10.1016/S0301-5629(03)00060-7
Frinking, P. J., Bouakaz, A., Kirkhorn, J., Ten Cate, F. J. & De Jong, N. Ultrasound contrast imaging: Current and new potential methods. Ultrasound Med. Biol. 26, 965–975 (2000).
pubmed: 10996696
doi: 10.1016/S0301-5629(00)00229-5
Gorce, J.-M., Arditi, M. & Schneider, M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: A study of SonoVue™. Invest. Radiol. 35, 661–671 (2000).
pubmed: 11110302
doi: 10.1097/00004424-200011000-00003
Kuenen, M. P., Mischi, M. & Wijkstra, H. Contrast-ultrasound diffusion imaging for localization of prostate cancer. IEEE Trans. Med. Imag. 30, 1493–1502 (2011).
doi: 10.1109/TMI.2011.2125981
Wei, K. et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 97, 473–483 (1998).
pubmed: 9490243
doi: 10.1161/01.CIR.97.5.473
Kooiman, K., Vos, H. J., Versluis, M. & de Jong, N. Acoustic behavior of microbubbles and implications for drug delivery. Adv. Drug Deliv. Rev. 72, 28–48 (2014).
pubmed: 24667643
doi: 10.1016/j.addr.2014.03.003
Kuenen, M., Saidov, T., Wijkstra, H. & Mischi, M. Contrast-ultrasound dispersion imaging for prostate cancer localization by improved spatiotemporal similarity analysis. Ultrasound Med. Biol. 39, 1631–1641 (2013).
pubmed: 23791350
doi: 10.1016/j.ultrasmedbio.2013.03.004
Cuenod, C. & Balvay, D. Perfusion and vascular permeability: Basic concepts and measurement in DCE-CT and DCE-MRI. Diagn. Interv. Imag. 94, 1187–1204 (2013).
doi: 10.1016/j.diii.2013.10.010
Smeenge, M. et al. First-in-human ultrasound molecular imaging with a VEGFR2-specific ultrasound molecular contrast agent (BR55) in prostate cancer: A safety and feasibility pilot study. Invest. Radiol. 52, 419–427 (2017).
pubmed: 28257340
doi: 10.1097/RLI.0000000000000362
Yin, T. et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int. J. Nanomed. 7, 895 (2012).
Perera, R. H. et al. Ultrasound imaging beyond the vasculature with new generation contrast agents. Wiley Interdis. Rev.: Nanomed. Nanobiotechnol. 7, 593–608 (2015).
Wu, H. et al. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. Ultrasound Med. Biol. 39, 2137–2146 (2013).
pubmed: 23932272
pmcid: 3786045
doi: 10.1016/j.ultrasmedbio.2013.05.007
Exner, A. A. & Kolios, M. C. Bursting microbubbles: How nanobubble contrast agents can enable the future of medical ultrasound molecular imaging and image-guided therapy. Curr. Opinion Coll. Interface Sci. 54, 101463 (2021).
doi: 10.1016/j.cocis.2021.101463
Pellow, C., Abenojar, E. C., Exner, A. A., Zheng, G. & Goertz, D. E. Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors. Theranostics 10, 11690 (2020).
pubmed: 33052241
pmcid: 7545999
doi: 10.7150/thno.51316
Ramirez, D. G. et al. Contrast-enhanced ultrasound with sub-micron sized contrast agents detects insulitis in mouse models of type1 diabetes. Nat. Commun. 11, 1–13 (2020).
doi: 10.1038/s41467-020-15957-8
Perera, R. H. et al. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles. Nanomed. Nanotechnol., Biol. Med. 28, 102213 (2020).
doi: 10.1016/j.nano.2020.102213
Wang, Y. et al. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA. Sci. Rep. 11, 1–12 (2021).
De, M., Ghosh, P. S. & Rotello, V. M. Applications of nanoparticles in biology. Adv. Mater. 20, 4225–4241 (2008).
doi: 10.1002/adma.200703183
Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015).
pubmed: 26348965
pmcid: 4978509
doi: 10.1038/nbt.3330
Cormode, D. P., Naha, P. C. & Fayad, Z. A. Nanoparticle contrast agents for computed tomography: A focus on micelles. Contrast Media Mol. Imag. 9, 37–52 (2014).
doi: 10.1002/cmmi.1551
Du, B., Yu, M. & Zheng, J. Transport and interactions of nanoparticles in the kidneys. Nat. Rev. Mater. 3, 358–374 (2018).
doi: 10.1038/s41578-018-0038-3
Dogra, P. et al. Mathematical modeling in cancer nanomedicine: A review. Biomed. Microdev. 21, 1–23 (2019).
doi: 10.1007/s10544-019-0380-2
Wu, H., Abenojar, E. C., Perera, R., An, T. & Exner, A. A. Time-intensity-curve analysis and tumor extravasation of nanobubble ultrasound contrast agents. Ultrasound Med. Biol. 45, 2502–2514 (2019).
pubmed: 31248638
pmcid: 6689247
doi: 10.1016/j.ultrasmedbio.2019.05.025
Perera, R. et al. Contrast enhanced ultrasound imaging by nature-inspired ultrastable echogenic nanobubbles. Nanoscale 11, 15647–15658 (2019).
pubmed: 31408083
pmcid: 6716144
doi: 10.1039/C9NR04828F
Hernandez, C. et al. Sink or float? Characterization of shell-stabilized bulk nanobubbles using a resonant mass measurement technique. Nanoscale 11, 851–855 (2019).
pubmed: 30601524
doi: 10.1039/C8NR08763F
Perera, R. et al. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles. Nanomed. Nanotechnol. Biol. Med. 28, 102213 (2020).
doi: 10.1016/j.nano.2020.102213
Turco, S., Tardy, I., Frinking, P., Wijkstra, H. & Mischi, M. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent. Phys. Med. Biol. 62, 2449 (2017).
pubmed: 28240217
doi: 10.1088/1361-6560/aa5e9a
Arditi, M., Frinking, P. J., Zhou, X. & Rognin, N. G. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 53, 1118–1129 (2006).
pubmed: 16846144
doi: 10.1109/TUFFC.2006.1642510
Turco, S. et al. Contrast-enhanced ultrasound quantification: From kinetic modeling to machine learning. Ultrasound Med. Biol. 46, 518–543 (2020).
pubmed: 31924424
doi: 10.1016/j.ultrasmedbio.2019.11.008
Turco, S., Wijkstra, H. & Mischi, M. Mathematical models of contrast transport kinetics for cancer diagnostic imaging: A review. IEEE Rev. Biomed. Eng. 9, 121–147 (2016).
pubmed: 27337725
doi: 10.1109/RBME.2016.2583541
Lammertsma, A. A. & Hume, S. P. Simplified reference tissue model for PET receptor studies. Neuroimage 4, 153–158 (1996).
pubmed: 9345505
doi: 10.1006/nimg.1996.0066
Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
pubmed: 32015543
pmcid: 7056644
doi: 10.1038/s41592-019-0686-2
Colman, M. W., Hornicek, F. J. & Schwab, J. H. Spinal cord blood supply and its surgical implications. J. Am. Acad. Orthop. Surg. 23, 581–591 (2015).
pubmed: 26377671
doi: 10.5435/JAAOS-D-14-00219
Kusters, Y. H. & Barrett, E. J. Muscle microvasculature’s structural and functional specializations facilitate muscle metabolism. Am. J. Physiol.-Endocrinol. Metab. 15, 310 (2016).
Nagy, J. A. et al. Heterogeneity of the tumor vasculature. Semin. Thromb. Hemost. 36, 321–331 (2010).
pubmed: 20490982
pmcid: 3278036
doi: 10.1055/s-0030-1253454
Nielsen, F. On a variational definition for the jensen-shannon symmetrization of distances based on the information radius. Entropy 23(4), 464 (2021).
pubmed: 33919986
pmcid: 8071043
doi: 10.3390/e23040464
DiCiccio, T. J. & Bradley, E. Bootstrap confidence intervals. Stat. Sci. 11(3), 189–228 (1996).
doi: 10.1214/ss/1032280214
L. E. Voorrips, L.E et al., A physical activity questionnaire for the elderly (1991).
Niewczas, M. A. et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J. Am. Soc. Nephrol. 23, 507–515 (2012).
pubmed: 22266663
pmcid: 3294310
doi: 10.1681/ASN.2011060627
Hu, P., Adler, N. E., Goldman, N., Weinstein, M. & Seeman, T. E. Relationship between subjective social status and measures of health in older Taiwanese persons. J. Am. Geriatr. Soc. 53, 483–488 (2005).
pubmed: 15743294
doi: 10.1111/j.1532-5415.2005.53169.x
Mischi, M., Kalker, T. A. & Korsten, E. H. Contrast echocardiography for pulmonary blood volume quantification. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 51, 1137–1147 (2004).
pubmed: 15478975
doi: 10.1109/TUFFC.2004.1334846
Rouwkema, J. & Khademhosseini, A. Vascularization and angiogenesis in tissue engineering: Beyond creating static networks. Trends Biotechnol. 34, 733–745 (2016).
pubmed: 27032730
doi: 10.1016/j.tibtech.2016.03.002
Jain, R. K. Determinants of tumor blood flow: A review. Can. Res. 48, 2641–2658 (1988).